Breaking News

We're excited to share that Vista Statistics is actively developing cutting-edge AI products to tackle some of the most pressing challenges in drug and biomarker discovery.

🔬 Accelerating Drug Discovery and Repurposing

Our AI-powered engine is designed to speed up drug discovery and identify new indications for existing compounds. By combining multi-omics integration, deep learning, and biomedical knowledge graphs, this platform aims to streamline candidate prioritization and reduce time-to-clinic.

🧬 Biomarker Discovery Through Mega Single-Cell Atlases

We are building robust tools to mine large-scale single-cell datasets across diverse conditions and tissues. These AI-driven methods are helping us discover novel biomarkers and regulatory pathways, paving the way for more precise diagnostics and targeted therapeutics.

Stay tuned as we bring these innovations closer to real-world applications—empowering researchers, clinicians, and patients alike.

Drug and CDx co-development
Bridging studies
Follow-On studies
Analytical studies
Accuracy studies

Precision Medicine

Dose optimization
Adaptive clinical trial design
Power and sample size estimation
Protocol review
TLFs
CSR review
Regulatory meeting support

Clinical Trial Support

Support for full publication circle
Full bioinformatics solutions
Customized methodology development and application
Survival and longitudinal data analysis
Real world evidence (RWE) analysis
Meta-analysis

Advanced Data Analysis

Breaking News

🔬 Accelerating Drug Discovery and Repurposing

🧬 Biomarker Discovery Through Mega Single-Cell Atlases

Contact us for collaboration and services

This website uses cookies.